The Role of Cardiomyopathic Troponin C Mutations in Skeletal and Cardiac Muscle C

心肌病肌钙蛋白 C 突变在骨骼肌和心肌 C 中的作用

基本信息

  • 批准号:
    8532964
  • 负责人:
  • 金额:
    $ 23.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-20 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary The cardiac troponin complex (CTn) is made up of cardiac troponin T (CTnT), that attaches the complex to the thin filament; cardiac troponin I (CTnI), involved in the inhibition of muscle contraction and cardiac/slow skeletal troponin C (CTnC), that binds Ca2+ and triggers contraction. Altogether, the CTn, regulates muscle contraction, i.e., Ca2+ sensitivity of force development, maximal force development and basal force. Cardiac/Slow Skeletal Troponin C (C/SSTnC) is the only component of CTn that is expressed and present in both cardiac and slow skeletal muscles. It is considered the primary Ca2+ sensor of striated muscle and has been a target of Hypertrophic (HCM) and Dilated (DCM) Cardiomyopathies. HCM or DCM are genetic disorders caused by the mutations in the TnC gene that are characterized by morphological changes in the ventricular walls and altered Ca2+ handling of the diseased heart. HCM mutations in troponin cause the cardiac myofilament to become sensitized to Ca2+ which is implicated as causing arrhythmias and sudden cardiac death. In contrast, troponin mutations related to DCM desensitize myofilaments to Ca2+ which often leads to congestive heart failure. CTn mutations related to cardiomyopathy have been extensively studied in the cardiac system. However, the functional consequences of cardiomyopathic C/SSTnC mutants also present in slow skeletal muscle are unknown. The question to be addressed in this grant is: What are the functional consequences of C/SSTnC mutations linked to HCM and DCM in the regulation of slow skeletal muscle contraction? How do they compare to those found in cardiac muscle? To accomplish this, in vitro systems will be utilized as well as skinned fibers which will be used to measure the force/pCa relationship. These measurements will be performed in both skeletal and cardiac muscles. An HCM CTnC knock-in mouse generated in the laboratory will be characterized to determine the in vivo consequences of the mutation in intact and skinned fibers. The aims of this proposal address the functional differences that underlie the phenotypes of C/SSTnC mutations in cardiac and skeletal muscles. These studies will investigate whether slow skeletal muscle containing C/SSTnC mutations develops skeletal abnormalities similar to those seen in the heart and whether the function of skeletal muscle is altered in the mutation-knock in mouse model. The questions that are being addressed are: Is the change that occurs in the skeletal system comparable to changes that occur in cardiac muscle? If the functional changes in slow skeletal muscle appear minimal what additional components absent in the regulation of cardiac muscle assist in rescuing the effects of the mutation? Successful execution of these aims will lead to a better understanding of cardiac versus slow skeletal muscle disorders associated with mutations in the TnC gene.
项目摘要 心肌肌钙蛋白复合物(CTn)由心肌肌钙蛋白T(CTnT)组成,其连接心肌肌钙蛋白T(CTnT)。 与细丝复合;心肌肌钙蛋白I(CTnI),参与抑制肌肉收缩 以及心脏/慢骨骼肌钙蛋白C(CTnC),其结合Ca 2+并触发收缩。一切器皿的银子 CTn调节肌肉收缩,即,力发展的Ca 2+敏感性,最大力 发展和基础力量。心脏/缓慢骨骼肌肌钙蛋白C(C/SSTnC)是 CTn在心肌和慢骨骼肌中表达和存在。它被认为是 横纹肌的主要Ca 2+传感器,并且一直是肥大(HCM)和扩张的目标 (DCM)心肌病。HCM或DCM是由TnC突变引起的遗传性疾病, 以心室壁的形态变化和Ca 2+改变为特征的基因 处理患病的心脏肌钙蛋白HCM突变导致心肌肌丝 对Ca 2+敏感,这与引起心律失常和心脏性猝死有关。与此相反, 与DCM相关的肌钙蛋白突变使肌丝对Ca 2+不敏感,这通常导致充血性心肌病。 心衰与心肌病相关的CTn突变已在心脏 系统然而,心肌病性C/SSTnC突变体的功能后果也 存在于慢骨骼肌中的未知。本补助金要解决的问题是: 是与HCM和DCM相关的C/SSTnC突变在调节 减缓骨骼肌收缩它们与心肌中发现的那些相比如何?到 为了实现这一点,将利用体外系统以及将用于 测量力/pCa关系。这些测量将在骨骼和 心肌在实验室中产生的HCM CTnC敲入小鼠将被表征为 确定在完整的和带皮的纤维中突变的体内后果。其目的是 该提案解决了C/SSTnC突变表型背后的功能差异, 心脏和骨骼肌。这些研究将调查是否缓慢骨骼肌含有 C/SSTnC突变会产生与心脏相似的骨骼异常, 在突变敲除小鼠模型中骨骼肌的功能改变。的问题 正在解决的问题是:骨骼系统中发生的变化是否与 发生在心肌中如果慢速骨骼肌的功能变化很小, 在心肌调节中不存在的另外的组分有助于挽救心肌收缩的作用。 变异?这些目标的成功实现将有助于更好地理解心脏与 与TnC基因突变相关的缓慢骨骼肌疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jose Renato Pinto其他文献

A Novel Mutation in <em>TNNC1-</em>ENCODED Cardiac Troponin C Predisposes to Hypertrophic Cardiomyopathy and Recurrent Episodes of Aborted Sudden Cardiac Death
  • DOI:
    10.1016/j.bpj.2010.12.832
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Michelle S. Parvatiyar;Andrew P. Landstrom;Jose Renato Pinto;Jingsheng Liang;Michael J. Ackerman;James D. Potter
  • 通讯作者:
    James D. Potter
Fetal Cardiac Troponin Isoforms Rescue the Increased Ca<sup>2+</sup> Sensitivity Produced by a Novel Double Deletion in Cardiac Troponin T Linked to Restrictive Cardiomyopathy
  • DOI:
    10.1016/j.bpj.2010.12.834
  • 发表时间:
    2011-02-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jose Renato Pinto;Shi Wei Yang;Marc-Phillip Hitz;Michelle S. Parvatiyar;Michelle A. Jones;Jingsheng Liang;Victor Kokta;Michelle Jaeggi;Gregor Andelfinger;James D. Potter
  • 通讯作者:
    James D. Potter
Protein Kinase a Phosphorylation of Cardiac Troponin I Prevents Cardiac Hypertrophy in Mice
  • DOI:
    10.1016/j.bpj.2009.12.797
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Yingcai Wang;Jose Renato Pinto;Raquel Sanchos-Solis;Jingsheng Liang;Zoraida Diaz-Perez;Keita Harada;Jeffery W. Walker;James D. Potter
  • 通讯作者:
    James D. Potter

Jose Renato Pinto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jose Renato Pinto', 18)}}的其他基金

Isolation, Characterization and Reconstruction of Vertebrate Striated Muscle Myosin Filaments
脊椎动物横纹肌肌球蛋白丝的分离、表征和重建
  • 批准号:
    10043292
  • 财政年份:
    2020
  • 资助金额:
    $ 23.27万
  • 项目类别:
Isolation, Characterization and Reconstruction of Vertebrate Striated Muscle Myosin Filaments
脊椎动物横纹肌肌球蛋白丝的分离、表征和重建
  • 批准号:
    10268975
  • 财政年份:
    2020
  • 资助金额:
    $ 23.27万
  • 项目类别:
Modulators of Cardiomyopathic Diseases
心肌病调节剂
  • 批准号:
    9914116
  • 财政年份:
    2016
  • 资助金额:
    $ 23.27万
  • 项目类别:
The Role of Cardiomyopathic Troponin C Mutations in Skeletal and Cardiac Muscle C
心肌病肌钙蛋白 C 突变在骨骼肌和心肌 C 中的作用
  • 批准号:
    8130800
  • 财政年份:
    2010
  • 资助金额:
    $ 23.27万
  • 项目类别:
The Role of Cardiomyopathic Troponin C Mutations in Skeletal and Cardiac Muscle C
心肌病肌钙蛋白 C 突变在骨骼肌和心肌 C 中的作用
  • 批准号:
    8528011
  • 财政年份:
    2010
  • 资助金额:
    $ 23.27万
  • 项目类别:
The Role of Cardiomyopathic Troponin C Mutations in Skeletal and Cardiac Muscle C
心肌病肌钙蛋白 C 突变在骨骼肌和心肌 C 中的作用
  • 批准号:
    7962716
  • 财政年份:
    2010
  • 资助金额:
    $ 23.27万
  • 项目类别:
The Role of Cardiomyopathic Troponin C Mutations in Skeletal and Cardiac Muscle C
心肌病肌钙蛋白 C 突变在骨骼肌和心肌 C 中的作用
  • 批准号:
    8677956
  • 财政年份:
    2010
  • 资助金额:
    $ 23.27万
  • 项目类别:

相似国自然基金

由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
  • 批准号:
    82360313
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Nuclear force feedback as rheostat for actomyosin tension control
核力反馈作为肌动球蛋白张力控制的变阻器
  • 批准号:
    MR/Y001125/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Research Grant
CAREER: Cytokinesis without an actomyosin ring and its coordination with organelle division
职业:没有肌动球蛋白环的细胞分裂及其与细胞器分裂的协调
  • 批准号:
    2337141
  • 财政年份:
    2024
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Continuing Grant
CAREER: Computational and Theoretical Investigation of Actomyosin Contraction Systems
职业:肌动球蛋白收缩系统的计算和理论研究
  • 批准号:
    2340865
  • 财政年份:
    2024
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Continuing Grant
Elucidation of the mechanism by which actomyosin emerges cell chirality
阐明肌动球蛋白出现细胞手性的机制
  • 批准号:
    23K14186
  • 财政年份:
    2023
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Deciphering actomyosin contractility regulation during incomplete germ cell division
破译不完全生殖细胞分裂过程中肌动球蛋白收缩性的调节
  • 批准号:
    573067-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 23.27万
  • 项目类别:
    University Undergraduate Student Research Awards
CAREER: Actuating robots with actomyosin active gels
职业:用肌动球蛋白活性凝胶驱动机器人
  • 批准号:
    2144380
  • 财政年份:
    2022
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Continuing Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201236
  • 财政年份:
    2022
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Standard Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201235
  • 财政年份:
    2022
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Standard Grant
Coordination of actomyosin and anillo-septin sub-networks of the contractile ring during cytokinesis
胞质分裂过程中收缩环肌动球蛋白和 anillo-septin 子网络的协调
  • 批准号:
    463633
  • 财政年份:
    2022
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Operating Grants
The integrin-dependent B cell actomyosin network drives immune synapse formation and B cell functions
整合素依赖性 B 细胞肌动球蛋白网络驱动免疫突触形成和 B 细胞功能
  • 批准号:
    546047-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 23.27万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了